Regulation & Compliance

MCF Energy's Welchau-1 well in Austria shows promising gas flows, a potential boost for regional energy independence amid ongoing geopolitical pressures.

A landmark trial shows Retevmo significantly cuts cancer recurrence in early-stage patients, pushing for a new standard of care and early genetic testing.

New research reveals the UK's booming sauna culture is more than just heat; it's a powerful social tool that could be prescribed to combat loneliness.

A landmark trial for Roche’s Gazyva shows unprecedented success in treating primary membranous nephropathy, offering hope of preventing kidney failure.

A West Virginia jury awarded millions to Pardee's subsidiary after a utility's power lines blocked access to coal, but a lengthy legal appeal looms.

With a new interim CEO and mounting financial pressure, VERSES AI's upcoming investor webinar is a pivotal test of its bio-inspired AI vision.

CenterWell's major acquisition of MaxHealth adds 82 clinics and 120,000 patients, deepening its hold on Florida's value-based senior care sector.

As state and federal cuts threaten vital services, Bloomington Health Foundation offers critical bridge funding to stabilize local nonprofits on the brink.

Disc Medicine's promising EPP drug hits a major roadblock as the FDA seeks more data, delaying hope for patients and setting up a high-stakes trial.

Canada's elections commissioner has sanctioned former minister Chrystia Freeland and others for breaking election laws, highlighting ongoing integrity challenges.

A new partnership signals a major shift in the art market, placing scientific conservation at the heart of determining an asset's long-term value.

South Easton's HUB Technical Services lands on CRN's prestigious Elite 150 list, recognized for its security-first approach to AI transformation.

Meltwater is now an Official Reddit Data Partner, unlocking a goldmine of unfiltered consumer insights. What does this mean for brands and data privacy?

With a $15 million funding boost, Nasus Pharma is accelerating its powder-based intranasal epinephrine, NS002, challenging the EpiPen's dominance.

Jasmine Hartin is vindicated as drug and assault charges are dismissed, raising questions about a 'weaponized' legal system in her ongoing public saga.

Irish firm InVera Medical wins CE Mark for a new varicose vein device, promising a less invasive, office-based treatment for a widespread condition.

Comparor launches its AI assistant, joining a tech race to simplify shopping and find the best price. But what does this mean for you and for retailers?

STADA and Bio-Thera's new golimumab biosimilar wins European approval, promising to slash healthcare costs and expand treatment access for millions.

Byreal's 2026 roadmap, revealed at Solana Accelerate, promises AI-driven liquidity and 24/7 real-world asset trading, aiming to woo institutions.

Magna beat Q4 expectations and raised its dividend, but a $591M tech impairment and looming Ford recall costs paint a complex picture for the auto giant.